A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients with Moderate to Severe Active Rheumatoid Arthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This is a Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 3 Study to Evaluate the Efficacy and Safety of Subcutaneous CT-P13 in Patients with Moderately to Severely Active Rheumatoid Arthritis
Epistemonikos ID: 050bebb4b97c5a430b25bb80b5f373ab6f802c21
First added on: Jan 01, 2025